Post by
Guytorule on Oct 25, 2024 3:45pm
Back on track.. (Stop loss selling over)
Rebound now regains the buying side, and we will see share price back to its .30 cent level. News to come out soon with regards to their response to FDA minor deficiencies and a possible new FDA goal date to its approval. It's a buying opportunity in my opinion. Took advance of the recent lows at .19 cent range for sure, and averaged down slowly. Now more confident of its approval and will look back with great confidence and satisfaction that my move was the right move to definitely average down on this multi bagger return. Hope many did as well..Good Luck!!!
Comment by
Sailormark on Oct 25, 2024 7:28pm
Where do you will think the share price will go upon an approval? $1.00? $2-3-4-5 plus?
Comment by
Itistoo on Oct 27, 2024 2:22pm
With FDA approval alone I think it would be in the 60 - 80 cent range. Needs some serious follow up news on contracts and revenue to even think about dollars. Don't forget they are getting very low on cash and without revenue will have to do an offering soon.
Comment by
Sailormark on Oct 28, 2024 8:39am
I do think an FDA approval will create a lot of volume and the traders will drive it to $1.00 plus very fast.